Read + Share
Lim JU. Management of Oligometastasis and Oligoprogression in Patients with Epidermal
Growth Factor Receptor Mutation-Positive NSCLC in the Era of Third-Generation
Tyrosine Kinase Inhibitors. Clin Lung Cancer 2021;22:e786-e792.
PMID: 33849807
|
 |
|
